These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 11804866
1. Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation: is it sufficient to treat severe pulmonary hypertension? Tuder RM, Zaiman AL. Am J Respir Cell Mol Biol; 2002 Feb; 26(2):171-4. PubMed ID: 11804866 [No Abstract] [Full Text] [Related]
3. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. Botney M. N Engl J Med; 1998 Jun 11; 338(24):1773-4. PubMed ID: 9625639 [No Abstract] [Full Text] [Related]
4. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation. Li Y, Connolly M, Nagaraj C, Tang B, Bálint Z, Popper H, Smolle-Juettner FM, Lindenmann J, Kwapiszewska G, Aaronson PI, Wohlkoenig C, Leithner K, Olschewski H, Olschewski A. Am J Respir Cell Mol Biol; 2012 Mar 11; 46(3):372-9. PubMed ID: 22021335 [Abstract] [Full Text] [Related]
5. Inhaled treprostinil for the treatment of pulmonary arterial hypertension. LeVarge BL, Channick RN. Expert Rev Respir Med; 2012 Jun 11; 6(3):255-65. PubMed ID: 22788940 [Abstract] [Full Text] [Related]
6. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets. Mercier O, Sage E, Izziki M, Humbert M, Dartevelle P, Eddahibi S, Fadel E. J Thorac Cardiovasc Surg; 2010 Sep 11; 140(3):677-83. PubMed ID: 20723731 [Abstract] [Full Text] [Related]
7. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension. Falcetti E, Hall SM, Phillips PG, Patel J, Morrell NW, Haworth SG, Clapp LH. Am J Respir Crit Care Med; 2010 Nov 01; 182(9):1161-70. PubMed ID: 20622039 [Abstract] [Full Text] [Related]
8. Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4. El-Haroun H, Bradbury D, Clayton A, Knox AJ. Circ Res; 2004 Feb 20; 94(3):353-61. PubMed ID: 14670842 [Abstract] [Full Text] [Related]
9. [Calcium and stored-operated Ca2+ channels in pulmonary vascular remodeling]. Wang J, Wang C. Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct 20; 30(10):784-6. PubMed ID: 18218215 [No Abstract] [Full Text] [Related]
10. In search of pulmonary hypertension treatments: Effect of 17β-estradiol on PGI2 pathway in human pulmonary artery. Amgoud Y, Senbel A, Bouhadoun A, Abdelazeem H, Ozen G, Savané I, Manikpurage HD, Mani S, Tran-Dinh A, Castier Y, Guyard A, Longrois D, Silverstein AM, Norel X. Prostaglandins Leukot Essent Fatty Acids; 2021 Sep 20; 172():102321. PubMed ID: 34403986 [Abstract] [Full Text] [Related]
11. Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. Nikam VS, Schermuly RT, Dumitrascu R, Weissmann N, Kwapiszewska G, Morrell N, Klepetko W, Fink L, Seeger W, Voswinckel R. Eur Respir J; 2010 Dec 20; 36(6):1302-14. PubMed ID: 20525716 [Abstract] [Full Text] [Related]
12. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Wharton J, Davie N, Upton PD, Yacoub MH, Polak JM, Morrell NW. Circulation; 2000 Dec 19; 102(25):3130-6. PubMed ID: 11120706 [Abstract] [Full Text] [Related]
13. Pharmacology of the single isomer, esuberaprost (beraprost-314d) on pulmonary vascular tone, IP receptors and human smooth muscle proliferation in pulmonary hypertension. Shen L, Patel JA, Norel X, Moledina S, Whittle BJ, von Kessler K, Sista P, Clapp LH. Biochem Pharmacol; 2019 Aug 19; 166():242-252. PubMed ID: 31158340 [Abstract] [Full Text] [Related]
14. The prostacyclin-mimetic cicaprost inhibits endogenous endothelin-1 release from human pulmonary artery smooth muscle cells. Wort SJ, Mitchell JA, Woods M, Evans TW, Warner TD. J Cardiovasc Pharmacol; 2000 Nov 19; 36(5 Suppl 1):S410-3. PubMed ID: 11078436 [Abstract] [Full Text] [Related]
16. Endogenously released endothelin-1 from human pulmonary artery smooth muscle promotes cellular proliferation: relevance to pathogenesis of pulmonary hypertension and vascular remodeling. Wort SJ, Woods M, Warner TD, Evans TW, Mitchell JA. Am J Respir Cell Mol Biol; 2001 Jul 19; 25(1):104-10. PubMed ID: 11472982 [Abstract] [Full Text] [Related]
17. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. McLaughlin VV, Genthner DE, Panella MM, Rich S. N Engl J Med; 1998 Jan 29; 338(5):273-7. PubMed ID: 9445406 [Abstract] [Full Text] [Related]
18. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery. Jones RL, Qian YM, Wise H, Wong HN, Lam WL, Chan HW, Yim AP, Ho JK. J Cardiovasc Pharmacol; 1997 Apr 29; 29(4):525-35. PubMed ID: 9156364 [Abstract] [Full Text] [Related]
19. Pharmacokinetic evaluation of continuous intravenous epoprostenol. Chaumais MC, Jobard M, Huertas A, Vignand-Courtin C, Humbert M, Sitbon O, Rieutord A, Montani D. Expert Opin Drug Metab Toxicol; 2010 Dec 29; 6(12):1587-98. PubMed ID: 21077785 [Abstract] [Full Text] [Related]
20. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells. Nicosia S, Oliva D, Bernini F, Fumagalli R. Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Dec 29; 17():593-9. PubMed ID: 6328938 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]